Henry Uppal

DNP Doctor of Nursing Practice,  CharitĂ© - Universitätsmedizin Berlin 

Location: India

Consulting Services

Grant Submission IT-Web-Mobile Technology Pharma-CRO-Device

Areas Of Interest

Malonitrile, o-Chlorobenzylidene Anal Gland Neoplasm Death, Cardiac Indwelling Catheters Miniaturized Electrodes TMJ Syndrome Alphavirus Infections Dichloroacetic Acid Long Chain Acyl Coenzyme A Dehydrogenase Sensitivity Tests, Microbial Raman Spectrum Analysis Tumor, Brain Ventricular Cytochrome P-450 Monooxygenase Inducers Luminescent Proteins Family Conflicts Infections, Flaviviridae Arm Injuries Genotoxicity Tests Antigens, CD110 Infections, Histoplasma Craniofacial Fibrous Dysplasia Enterochromaffin-like Cell Behaviors, Appetitive Alcinonide Anti-Arrhythmia Agents Health Care System Bacterial Proteins CT PET Semiochemicals Procedures, Colonoscopic Surgical Indicator, Health Status

Professional Narrative

Dr. Henry Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 1988
Executive Director, Mayo Clinic 2000

Education

Bachelor of science in nursing, Baylor College 1989
Doctor of medicine, Baylor College 2002

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :